Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Head and Neck Neoplasms 2Weight Loss 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Inflammation 1Feeding Behavior 1Colorectal Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1

Interventions

Cisplatin 258Radiotherapy 193Cetuximab 151pembrolizumab 123Docetaxel 97Fluorouracil 92Carboplatin 80Paclitaxel 78Radiotherapy, Intensity-Modulated 72Surveys and Questionnaires 46Nivolumab 42Drug Therapy 34Radiation 33Blood Specimen Collection 27Erlotinib Hydrochloride 26Gemcitabine 25Immunohistochemistry 22Gefitinib 22Cyclophosphamide 22Surgical Procedures, Operative 21Standard of Care 20durvalumab 19Pemetrexed 19Magnetic Resonance Spectroscopy 19Radiosurgery 17Capecitabine 17Chemotherapy, Adjuvant 16Celecoxib 16Biopsy 16atezolizumab 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Head and Neck Neoplasms × Diet Records × Clear all
NCT05997329 2025-09-08

NUTREAT

University of Oslo

Phase NA Active not recruiting
125 enrolled
Head & Neck

Head and Neck Neoplasms

NCT02557529 2020-05-27

Progressive Resistance Training in Head and Neck Cancer Patients During Concomitant Chemoradiotherapy

Herlev Hospital

Phase NA Terminated
50 enrolled
Head & Neck

Head and Neck Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡